Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-′4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide Y5 (NPY5) ligands for the treatment of obesity

2-′4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide Y5 (NPY5) ligands for the treatment of obesity

US Patent 7888510 · Granted Feb 15, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Kits comprising containers with at least one solid catalytically active compound2025
Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propy2023
Use of sodium channel blockers for the treatment of neuropathic pain developing 2022
Use of sodium channel blockers for the treatment of neuropathic pain developing 2020
Use of sodium channel blockers for the treatment of neuropathic pain developing 2018
1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of op2018
Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compoun2017
Cap/endo dual inhibitors and their use in the treatment, amelioration or prevent2017
Substituted 1,5-naphthyridines as endonuclease inhibitors2016
7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment,2016
Co-crystals of tramadol and NSAIDs2016
Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compoun2016